143 related articles for article (PubMed ID: 34604685)
1. Synthesis of Sulfonamide Tethered (Hetero)aryl ethylidenes as Potential Inhibitors of P2X Receptors: A Promising Way for the Treatment of Pain and Inflammation.
Mahmood A; Munir R; Zia-Ur-Rehman M; Javid N; Shah SJA; Noreen L; Sindhu TA; Iqbal J
ACS Omega; 2021 Sep; 6(38):25062-25075. PubMed ID: 34604685
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of adamantane-1-carbonyl thiourea derivatives as potent and selective inhibitors of h-P2X4 and h-P2X7 receptors: An Emerging therapeutic tool for treatment of inflammation and neurological disorders.
Mahmood A; Ali Shah SJ; Iqbal J
Eur J Med Chem; 2022 Mar; 231():114162. PubMed ID: 35123298
[TBL] [Abstract][Full Text] [Related]
3. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.
Cho JH; Jung KY; Jung Y; Kim MH; Ko H; Park CS; Kim YC
Eur J Med Chem; 2013; 70():811-30. PubMed ID: 24246730
[TBL] [Abstract][Full Text] [Related]
6. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
[TBL] [Abstract][Full Text] [Related]
7. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of cloned P2X receptors.
North RA; Surprenant A
Annu Rev Pharmacol Toxicol; 2000; 40():563-80. PubMed ID: 10836147
[TBL] [Abstract][Full Text] [Related]
9. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
10. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
Lewis CJ; Evans RJ
Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of glutamate and GABA release by P2X receptor activation in supraoptic neurons from freshly isolated rat brain slices.
Vavra V; Bhattacharya A; Zemkova H
Neuroscience; 2011 Aug; 188():1-12. PubMed ID: 21575687
[TBL] [Abstract][Full Text] [Related]
12. The Molecular Determinants of Small-Molecule Ligand Binding at P2X Receptors.
Pasqualetto G; Brancale A; Young MT
Front Pharmacol; 2018; 9():58. PubMed ID: 29456508
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of P2X receptors expressed in rat pulmonary arteries.
Syed NI; Tengah A; Paul A; Kennedy C
Eur J Pharmacol; 2010 Dec; 649(1-3):342-8. PubMed ID: 20868665
[TBL] [Abstract][Full Text] [Related]
14. Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
Michel AD; Kaur R; Chessell IP; Humphrey PP
Br J Pharmacol; 2000 Jun; 130(3):513-20. PubMed ID: 10821778
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and molecular characterization of P2X receptors in rat pelvic ganglion neurons.
Zhong Y; Dunn PM; Xiang Z; Bo X; Burnstock G
Br J Pharmacol; 1998 Oct; 125(4):771-81. PubMed ID: 9831914
[TBL] [Abstract][Full Text] [Related]
16. TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics.
Honore P; Mikusa J; Bianchi B; McDonald H; Cartmell J; Faltynek C; Jarvis MF
Pain; 2002 Mar; 96(1-2):99-105. PubMed ID: 11932066
[TBL] [Abstract][Full Text] [Related]
17. P2X1 and P2X2 receptors in the central nervous system as possible drug targets.
Hausmann R; Schmalzing G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):675-86. PubMed ID: 22963438
[TBL] [Abstract][Full Text] [Related]
18. Vatalanib decrease the positive interaction of VEGF receptor-2 and P2X2/3 receptor in chronic constriction injury rats.
Liu S; Xu C; Li G; Liu H; Xie J; Tu G; Peng H; Qiu S; Liang S
Neurochem Int; 2012 May; 60(6):565-72. PubMed ID: 22361062
[TBL] [Abstract][Full Text] [Related]
19. P2X receptor antagonists for pain management: examination of binding and physicochemical properties.
Gum RJ; Wakefield B; Jarvis MF
Purinergic Signal; 2012 Feb; 8(Suppl 1):41-56. PubMed ID: 22086553
[TBL] [Abstract][Full Text] [Related]
20. Medicinal chemistry of P2X receptors: allosteric modulators.
Müller CE
Curr Med Chem; 2015; 22(7):929-41. PubMed ID: 25524251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
